MedKoo Cat#: 573346 | Name: AX-048
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AX-048 is a potent group IVA cPLA2 inhibitor. The group IVA phospholipase A2 (PLA2), known as calcium-dependent cytosolic PLA2 (cPLA2), selectively releases arachidonic acid from membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins and leukotrienes.

Chemical Structure

AX-048
AX-048
CAS#873079-69-7

Theoretical Analysis

MedKoo Cat#: 573346

Name: AX-048

CAS#: 873079-69-7

Chemical Formula: C22H41NO4

Exact Mass: 383.3036

Molecular Weight: 383.57

Elemental Analysis: C, 68.89; H, 10.77; N, 3.65; O, 16.68

Price and Availability

Size Price Availability Quantity
500µg USD 350.00 2 Weeks
1mg USD 650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
AX-048
IUPAC/Chemical Name
Butanoic acid, 4-((1,2-dioxohexadecyl)amino)-, ethyl ester
InChi Key
FMFKQXKYWWJNJS-UHFFFAOYSA-N
InChi Code
1S/C22H41NO4/c1-3-5-6-7-8-9-10-11-12-13-14-15-17-20(24)22(26)23-19-16-18-21(25)27-4-2/h3-19H2,1-2H3,(H,23,26)
SMILES Code
CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)OCC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 383.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Antonopoulou G, Magrioti V, Kokotou MG, Nikolaou A, Barbayianni E, Mouchlis VD, Dennis EA, Kokotos G. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity. Bioorg Med Chem. 2016 Oct 1;24(19):4544-4554. doi: 10.1016/j.bmc.2016.07.057. Epub 2016 Jul 27. PubMed PMID: 27522578; PubMed Central PMCID: PMC5014611. 2: Yaksh TL, Kokotos G, Svensson CI, Stephens D, Kokotos CG, Fitzsimmons B, Hadjipavlou-Litina D, Hua XY, Dennis EA. Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal prostaglandin E2 release. J Pharmacol Exp Ther. 2006 Jan;316(1):466-75. Epub 2005 Oct 3. PubMed PMID: 16203828.